Apart from their adverse effects, the drugs available for treating toxoplasmosis, most especially the first line agents, were reported to be less efficient on the parasite as well as another related genus, Plasmodium, because of mutation in dihydropteroate synthase (DHPS) gene. The gene discussed is DHPS; the disease is toxoplasmosis.